Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 0 call positions (— notional), 5 put positions ($249.2m notional) – listed below, not included above.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NATERA INC NTRA | $117.5m12.40% | Reduced -406.0k |
| GSK PLC GSK | $103.8m10.96% | Reduced -850.5k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $57.7m6.10% | Added +1.5m |
| UNITED THERAPEUTICS CORP DEL UTHR | $57.5m6.07% | Added +38.3k |
| HORIZON THERAPEUTICS PUB L HZNP | $48.9m5.16% | Reduced -343.8k |
| SYNDAX PHARMACEUTICALS INC SNDX | $45.8m4.84% | Reduced -19.3k |
| COMMUNITY HEALTH SYS INC NEW CYH | $32.0m3.38% | Reduced -1.8m |
| BIO-TECHNE CORP TECH | $28.0m2.95% | Added +154.0k |
| VERA THERAPEUTICS INC VERA | $27.9m2.95% | Reduced -47.6k |
| INSPIRE MED SYS INC INSP | $26.8m2.83% | New |
| CELLDEX THERAPEUTICS INC NEW CLDX | $26.7m2.82% | Added +96.1k |
| DANAHER CORPORATION DHR | $24.8m2.62% | Reduced -45.3k |
| HCA HEALTHCARE INC HCA | $24.5m2.59% | Added +52.8k |
| ILLUMINA INC ILMN | $23.3m2.46% | Reduced -46.5k |
| ICON PLC ICLR | $17.9m1.90% | Reduced -5.1k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.7m1.76% | Reduced -2.1m |
| AMNEAL PHARMACEUTICALS INC AMRX | $16.3m1.72% | Added +82.2k |
| CATALENT INC CTLT | $15.5m1.63% | Reduced -216.7k |
| SERES THERAPEUTICS INC COM | $14.7m1.56% | Added +540.1k |
| KRYSTAL BIOTECH INC KRYS | $12.5m1.32% | New |
| AMARIN CORP PLC SPONS ADR NEW | $12.5m1.32% | New |
| ABCAM PLC ADS | $12.2m1.29% | New |
| CENTENE CORP DEL CNC | $10.3m1.09% | Reduced -135.7k |
| IONIS PHARMACEUTICALS INC IONS | $9.9m1.05% | Reduced -61.8k |
| VAXCYTE INC PCVX | $9.8m1.03% | Reduced -103.4k |
| TARO PHARMACEUTICAL INDS LTD TARO | $9.5m1.00% | Added +5.0k |
| REPLIGEN CORP RGEN | $9.3m0.99% | Added +60.4k |
| INFLARX NV IFRX | $8.5m0.90% | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $8.2m0.87% | Added +646.5k |
| MODEL N INC MODN | $7.9m0.83% | Reduced -18.7k |
| LIQUIDIA CORPORATION LQDA | $7.3m0.77% | Added +201.0k |
| XENON PHARMACEUTICALS INC XENE | $6.6m0.70% | Reduced -31.9k |
| MOLINA HEALTHCARE INC MOH | $6.4m0.68% | New |
| PUMA BIOTECHNOLOGY INC PBYI | $5.9m0.62% | Reduced -279.9k |
| SHOCKWAVE MED INC SWAV | $5.7m0.61% | Reduced -27.4k |
| HUMANA INC HUM | $5.3m0.56% | Reduced -10.8k |
| PENNANT GROUP INC PNTG | $5.3m0.56% | Added +9.6k |
| APELLIS PHARMACEUTICALS INC APLS | $5.1m0.54% | New |
| KURA ONCOLOGY INC KURA | $4.8m0.50% | New |
| IQVIA HLDGS INC IQV | $4.2m0.45% | Added +4.3k |
| EHEALTH INC EHTH | $4.0m0.43% | Reduced -731.2k |
| MEDPACE HLDGS INC MEDP | $3.7m0.39% | Added +3.9k |
| CUREVAC N V CVAC | $3.7m0.39% | New |
| SUTRO BIOPHARMA INC COM | $3.5m0.37% | New |
| MERUS N V MRUS | $3.5m0.36% | Added +2.2k |
| AGILENT TECHNOLOGIES INC A | $3.4m0.36% | Added +15.3k |
| PROTAGONIST THERAPEUTICS INC PTGX | $3.2m0.33% | New |
| BIOHAVEN LTD BHVN | $3.1m0.33% | Reduced -54.5k |
| PARATEK PHARMACEUTICALS INC PRTK | $2.9m0.31% | Added +689.4k |
| WATERS CORP WAT | $2.9m0.31% | New |
| REVVITY INC RVTY | $2.5m0.27% | Added +9.0k |
| BLACK DIAMOND THERAPEUTICS I BDTX | $2.2m0.23% | New |
| GOHEALTH INC CL A NEW | $2.1m0.22% | Reduced -20.2k |
| XOMA ROYALTY CORPORATION XOMA | $1.7m0.18% | Unchanged |
| EVOLUS INC EOLS | $1.7m0.18% | Added +7.1k |
| ARGENX SE ARGX | $1.6m0.17% | Added +318 |
| ZAI LAB LTD ZLAB | $1.5m0.16% | Reduced -116.8k |
| ELEVANCE HEALTH INC ELV | $1.0m0.11% | New |
| AFFIMED N V COM | $1.0m0.11% | Reduced -207.1k |
| GOSSAMER BIO INC GOSS | $899.6k0.10% | Reduced -602.4k |
| AEROVATE THERAPEUTICS INC COM | $861.6k0.09% | Unchanged |
| UROGEN PHARMA LTD URGN | $774.1k0.08% | New |
| AADI BIOSCIENCE INC WHWK | $697.1k0.07% | Unchanged |
| AC IMMUNE SA ACIU | $368.2k0.04% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $326.9k0.03% | New |
| FIBROGEN INC COM | $15.1k0.00% | New |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| BIOGEN INC BIIB | $42.8m153.8k shares |
| AVANTOR INC AVTR | $15.2m717.6k shares |
| INTRA-CELLULAR THERAPIES INC ITCI | $11.8m218.7k shares |
| GUARDANT HEALTH INC GH | $11.3m483.1k shares |
| TENET HEALTHCARE CORP THC | $8.4m141.9k shares |
| HESKA CORP HSKA | $2.6m26.4k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $129.3m350.0k shares | Reduced |
| SPDR S&P 500 ETF TR SPY · Put | $102.0m230.0k shares | Reduced |
| AMN HEALTHCARE SVCS INC AMN · Put | $10.4m95.0k shares | Added |
| SPDR SER TR XBI · Put | $7.5m90.0k shares | Added |
| FIBROGEN INC Put | $104.8k38.8k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |